BI
VBIV

BVF Inc’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

BVF Inc’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-157,419
Closed -$8.83M – 60
2019
Q1 		$8.83M Sell
157,419
-16,476
-9% -$891K 0.99% 33
2018
Q4 		$8.35M Buy
173,895
+70,562
+68% +$3.87M 1.09% 29
2018
Q3 		$7.5M Hold
103,333
– – 0.66% 39
2018
Q2 		$8.53M Hold
103,333
– – 0.83% 34
2018
Q1 		$10.8M Hold
103,333
– – 1.1% 25
2017
Q4 		$13.2M Buy
+103,333
New +$12.7M 1.6% 20

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BVF Inc's VBIV Position: Q2 2019 in Review

BVF Inc sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2019, closing a stake of 157,419 shares — an estimated $8.83M sold.

BVF Inc first reported a position in VBIV in Q4 2017 and held it in 6 quarters. The position peaked at $13.2M in Q4 2017. 56 funds tracked by Wall St. Rank hold VBIV as of Q2 2019.

  • BVF Inc reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2019 after selling out during the quarter.
  • BVF Inc sold 157,419 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2019, an estimated $8.83M.
  • BVF Inc first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 6 quarters.
  • BVF Inc's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $13.2M in Q4 2017.
  • 56 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2019.

Based on BVF Inc's 13F filing for Q2 2019, filed 14 Aug 2019.